| Literature DB >> 35020124 |
Francis R Loayza1,2, Ignacio Obeso3,4, Rafael González Redondo4,5, Federico Villagra1, Elkin Luis1, José A Obeso3,4, Marjan Jahanshahi6, Maria A Pastor7,8.
Abstract
Recent imaging studies with the stop-signal task in healthy individuals indicate that the subthalamic nucleus, the pre-supplementary motor area and the inferior frontal gyrus are key components of the right hemisphere "inhibitory network". Limited information is available regarding neural substrates of inhibitory processing in patients with asymmetric Parkinson's disease. The aim of the current fMRI study was to identify the neural changes underlying deficient inhibitory processing on the stop-signal task in patients with predominantly left-sided Parkinson's disease. Fourteen patients and 23 healthy controls performed a stop-signal task with the left and right hands. Behaviorally, patients showed delayed response inhibition with either hand compared to controls. We found small imaging differences for the right hand, however for the more affected left hand when behavior was successfully inhibited we found reduced activation of the inferior frontal gyrus bilaterally and the insula. Using the stop-signal delay as regressor, contralateral underactivation in the right dorsolateral prefrontal cortex, inferior frontal and anterior putamen were found in patients. This finding indicates dysfunction of the right inhibitory network in left-sided Parkinson's disease. Functional connectivity analysis of the left subthalamic nucleus showed a significant increase of connectivity with bilateral insula. In contrast, the right subthalamic nucleus showed increased connectivity with visuomotor and sensorimotor regions of the cerebellum. We conclude that altered inhibitory control in left-sided Parkinson's disease is associated with reduced activation in regions dedicated to inhibition in healthy controls, which requires engagement of additional regions, not observed in controls, to successfully stop ongoing actions.Entities:
Keywords: Dopamine; Functional connectivity; Imaging; Inhibition; Parkinson’s disease; Stop-signal reaction time task; Subthalamic nucleus; fMRI
Mesh:
Year: 2022 PMID: 35020124 PMCID: PMC9107438 DOI: 10.1007/s11682-021-00587-5
Source DB: PubMed Journal: Brain Imaging Behav ISSN: 1931-7557 Impact factor: 3.224
Demographic and clinical details of the samples. Data are means with standard deviations given in brackets
| PD | Controls | ||
|---|---|---|---|
| Age (years) | 54.7 (8.5) | 57.6 (8.6) | |
| Sex (male / female) | 7 / 7 | 12 / 11 | |
| MMSE | 29.4 (2.2) | 30.0 (0.7) | |
| Handedness | 49.1 (3.0) | 49.9 (0.2) | |
| Disease duration (years) | 6.8 (3.5) | N/A | N/A |
| BIS-11 | 46.36(14.2) | 34.92(9.0) | |
| H&Y | 2.18(0.5) | N/A | N/A |
UPDRS (OFF) left/right hemi-body | 22.4 (3.3)/ 7.36 (3.5) | N/A | |
UPDRS (ON) left/right hemi-body | 8.4 (2.8) / 4.5 (2.7) | N/A | |
| L-Dopa dosage (mg/day) | 636.0 (343.9) | N/A | N/A |
PD: Parkinson’s disease, MMSE: mini mental state examination, UPDRS: Unified Parkinson’s disease rating Scale; UPDRS: Unified Parkinson’s Disease Rating Scale; mg: milligrams. Non-parametric tests were used for group comparisons (Mann–Whitney tests) and within-subjects (Kolmogorov–Smirnov tests)
Fig. 1The stop signal task sequence of events of the two types of trials. 1) “Go” trials, where the participant is requested to press the left or right button on presentation of a left or right pointing arrow respectively presented in the (*) block. 2) “Stop” trials where the participant is requested to inhibit the movement when a beep (‡ stop signal) is presented after the Go signal. The stop signal delay, the interval between the Go and Stop signals, was varied between 50 and 450 ms and adjusted using a staircase tracking procedure depending on the reaction time and the participant’s success/failure in motor inhibition
Means and standard deviation (in brackets) for the measures of interest on the stop signal reaction time task for patients with left-sided Parkinson’s Disease (PD) and for healthy controls performing the task with their right or left hands
| Measure | PD | Controls | stats | ||
|---|---|---|---|---|---|
| Right hand | Left hand | Right hand | Left hand | ||
| Go RT (ms) | 518.73 (95.4) | 522.87 (109.9) | 422.98 (52.7) | 421.67 (65.2) | |
| Stop Inhibit (%) | 61.60 (16.7) | 62.04 (16.9) | 59.05 (13.5) | 60.20 (12.1) | |
| Stop Respond RT (ms) | 422.82 (75.6) | 435.49 (112.2) | 381.67 (45.0) | 373.01 (52.2) | + |
| Go errors | 0.85 (1.2) | 1.00 (1.5) | 0.57 (1.2) | 0.73 (0.9) | |
| Stop Signal Delay (ms) | 189.32 (19.3) | 191.05 (40.1) | 236.96 (48.3) | 238.27 (27.5) | |
| Stop Signal Reaction Time (ms) | 307.34 (103.3) | 316.70 (123.3) | 239.86 (60.3) | 247.37 (53.3) | |
ms: milliseconds; mixed ANOVA results in statistics column show Group ( +), Hand (#) or their interaction (¬) effects. Non-parametric tests were used in percentage and error comparisons (¢)
Fig. 2The mean Go RTs (A), stop signal delay (SSD; B) and stop-signal reaction time (C) derived using the integration stop-signal reaction time (iSSRT) for the patients with left predominance of arkinson’s disease (LPD) and healthy controls (HC) when completing the task with their right or left hands
Fig. 3Brain regions under-activated in left-sided Parkinson’s disease patients compared to healthy controls during the successful inhibition condition for the most affected left hand. Panel A shows significant underactivations when comparing left vs. right hand in the patients group. We did not find significant differences between hands for the control group. Panel B depict brain regions underactivated when comparing the left hand with the control group during Stop-Inhibit task. We did not find significant differences for the right hand for this contrast. No significant hyperactive regions prevailed threshold
Fig. 4Main effect of Group for the Go and Stop-Inhibit vs. Go contrasts. Hot (red) colors indicate brain regions showing overactivation and cold (blue) colors underactivation in patients with left-sided Parkinson’s disease (PD) compared to healthy controls (HCs). Panel A: plot of percent signal change (PSC) for left and right insula and medial pre-SMA for left and right hand. Panel B: significant brain regions under-activated in left-sided PD patients compared to HCs during the Go trials for the right hand. Panel C: significant underactivation for Stop-Inhibit vs. Go contrast for the left hand, and panel D: significant overactivation of the patients for the Stop-Inhibit vs. Go contrast for the right hand
Fig. 5Areas showing underactivation for the left-sided Parkinson Disease group compared with the healthy control group using the SSD (Stop Signal Delay) as regressor. Thus, the successful inhibition trials were weighted with the difficulty level. Figure shows areas of underactivation when patients performed the task with the right hand
Fig. 6Psychophysiological Interaction differences between patients and controls of the left and right STNs during Stop-Inhibit trials (successful inhibition) with their left hand. Hot colors show significant increases of functional connectivity for the patients. Panel A: connectivity increases of the left STN. Bottom image shows key regions tested using small volume correction (SVC); Panel B: connectivity increases of the right STN. We did not find any significant changes of functional connectivity of the left or right STNs for the right hand